Timothy P. LaBranche

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

Kamran Ghoreschi, Michael I. Jesson, Li Xiong et al. · The Journal of Immunology · 2011 · 644 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutations

Erica Evans, Alexandra K. Gardino, Joseph L. Kim et al. · Science Translational Medicine · 2017 · 214 citations

Medicine, Oncology, Pharmacology +10

Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia

Joseph F. Nabhan, Kristy Wood, Varada P. Rao et al. · Scientific Reports · 2016 · 137 citations · Full text

Pharmacy, Neuroscience, Pharmacology +17

JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production

Timothy P. LaBranche, Michael I. Jesson, Chad Storer et al. · Arthritis & Rheumatism · 2012 · 136 citations

Medicine, Immunology, Pharmacology +17

Th17 cells can provide B cell help in autoantibody induced arthritis

Cynthia L. Hickman‐Brecks, Jennifer Racz, Debra M. Meyer et al. · Journal of Autoimmunity · 2010 · 70 citations · Full text

Life Sciences, Immunology, Pathobiology +14